USD 0.0
(-4.76%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | 613.00 USD | -63.94% |
2023 | 1700.00 USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 613.00 USD | -14.27% |
2024 Q1 | 715.00 USD | -57.94% |
2024 FY | 613.00 USD | -63.94% |
2024 Q4 | 613.00 USD | -0.16% |
2024 Q3 | 614.00 USD | 0.16% |
2023 FY | 1700.00 USD | 0.0% |
2023 Q4 | 1700.00 USD | 2198.77% |
2023 Q3 | -81.00 USD | 0.0% |
2023 Q2 | - USD | 100.0% |
2023 Q1 | -4419.00 USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q2 | -1395.00 USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 Q3 | - USD | 100.0% |
2022 FY | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2020 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
China Medicine Corporation | 2.73 Million USD | 99.978% |
Exlites Holdings International, Inc. | - USD | -Infinity% |
Itonis, Inc. | - USD | -Infinity% |
One Step Vending Corp. | 2655.00 USD | 76.911% |
MediPal Holdings Corporation | 1.13 Billion USD | 100.0% |
PD-Rx Pharmaceuticals, Inc. | 1.64 Million USD | 99.963% |
Pharmagen, Inc. | 136.97 USD | -347.543% |
Suzuken Co., Ltd. | 940.54 Million USD | 100.0% |